https://www.selleckchem.com/pr....oducts/l-ornithine-l
0001) and colonic (p less then 0.05) weight. Increased villus height was recorded in the duodenum (p less then 0.001) and crypt depth was increased in the duodenum and jejunum (p less then 0.05 and p less then 0.05). Disruption of glucagon receptor signaling did not affect body weight during AOM/DSS treatment, neither did it affect the inflammatory score assessed during colonoscopy or the number of large and small adenomas present at the end of the study period. In conclusion, despite the increased endogenous GLP-2 secre
Like
Comment
Share
